v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (1,717,372) $ (3,191,653)
Adjustments to reconcile net loss to cash provided by (used) in operating activities:    
Change in fair value of investment (107,234) 0
Change in fair value of derivative liability 0 266,891
Depreciation, depletion and amortization 0 136,847
Amortization of right-of-use assets 0 410,832
Amortization of debt discount 793,381 793,381
Foreign currency translation adjustment 0 84,272
Changes in operating assets and liabilities:    
Accounts receivable, net 0 847,502
Inventory 37,980 1,316,401
Insurance proceeds receivable (10,286,000) 0
Prepaids and other current assets (224,709) (218,355)
Accounts payable and other accrued expenses 485,221 (260,171)
Accrued interest 404,757 414,052
Accrued litigation settlement 10,286,000 0
Due to related parties 0 200,464
Customer deposits 0 (167,027)
Operating lease liabilities 0 (391,476)
Net cash provided by (used in) operating activities (327,976) 241,960
Cash flows from investing activities:    
Acquisition of fixed assets 0 (16,136)
Payment received on note receivable from related party 342,974 0
Net cash used in investing activities 342,974 (16,136)
Cash flows from financing activities:    
Repayment of long-term debt (729) (702)
Advances from (repayment of) bank credit facility 0 (154,676)
Repayment of promissory notes, related parties 0 (16,170)
Net cash provided by (used in) financing activities (729) (171,548)
Net increase in cash 14,269 54,276
Cash and cash equivalents, beginning of period 279,525 114,648
Cash and cash equivalents, end of period 293,794 168,924
Cash paid for:    
Interest 4,669 79,306
Income taxes 0 0
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Issuance of shares on true-up of Series C Preferred Stock 0 1,063,265
Acquisition of right of use assets through operating lease $ 0 $ 289,896